Rubella is a viral infectious disease caused by the rubella virus of the Togaviridae family. The infection is mild but has serious consequences for pregnant women, especially in the first trimester, when fetal malformations may develop. The virus is transmitted by airborne droplets, making rubella a highly contagious disease. The main symptoms of rubella are rash, fever, enlarged lymph nodes, conjunctivitis, and catarrhal symptoms. The nature of the virus and its pathogenesis determine the various clinical manifestations of the disease, often leading to underestimation of the severity of the infection.
History of the disease and interesting historical facts
Rubella was first described in 1814 by a pediatrician, but the disease itself had been known for a long time before that, and was often confused with other infections, such as measles or scarlet fever. In the mid-20th century, rubella was considered a minor illness until it was discovered that the infection could cause severe birth defects in the fetus during pregnancy. Adherence to rubella vaccination increased after epidemics in the 1960s, when many cases arose in the United States associated with increased morbidity among pregnant women. Vaccination was introduced in 1969, which significantly reduced the incidence of rubella in developed countries.
Epidemiology
Rubella epidemiology shows a significant decline in cases since the introduction of vaccination against it. According to the World Health Organization, in 2000, the incidence rate worldwide was 1.4 million cases, while in 2020 there were only about 9,000 cases. Rubella incidence varies significantly by region: in countries with high vaccination rates, the number of cases is an order of magnitude lower than in regions where vaccination is not mandatory. According to the latest data, the number of rubella cases in Europe and America is close to zero, while in Africa and Asia, the infection continues to be registered much more often.
Genetic predisposition to this disease
Rubella is caused by a virus, and there is no direct genetic predisposition to the disease. However, there are genetic factors that may influence susceptibility to the virus. There is evidence that certain polymorphisms in genes responsible for the immune response may increase the risk of rubella infection. For example, variations in genes associated with the production of interferons may lead to a weakened immune response to rubella. The relationship between genetics and susceptibility to infectious diseases requires further research, and at present there are no specific mutations that are directly associated with rubella.
Risk factors for the development of this disease
Risk factors for developing rubella include the following:
- Unvaccinated populations are the most vulnerable category to infection.
- Pregnancy is the most dangerous period, as the infection can lead to serious fetal malformations.
- Contact with infected people in closed groups (schools, kindergartens).
- Immunodeficiencies and concomitant diseases that may reduce the body's ability to fight the virus.
- Lack of awareness about the disease and methods of prevention.
Diagnosis of this disease
Diagnosis of rubella is based on clinical examination, medical history and laboratory tests. The main symptoms include:
- Rash: Pinkish spots that start on the face and spread over the body.
- Fever: moderate increase in body temperature.
- Enlarged lymph nodes, especially behind the ear.
- Conjunctivitis and catarrhal symptoms (runny nose, cough).
Laboratory testing may include serologic tests for IgM and IgG antibodies to rubella virus. Radiologic testing is usually not required. Differential diagnosis includes measles, scarlet fever, and other exanthematous diseases.
Treatment
Treatment for rubella is usually symptomatic, as there is no specific antiviral treatment. It includes:
- Drink plenty of fluids to maintain water balance.
- Taking antipyretics (paracetamol or ibuprofen) at high temperatures.
- Help with allergic rash reactions with antihistamines.
- In case of complications such as encephalitis, hospitalization and specialized treatment may be required.
It is important for pregnant women to consult with their doctor to assess potential risks and consequences.
List of medications used to treat this disease
There is currently no targeted treatment for rubella. However, the following medications may be used for symptomatic treatment:
- Paracetamol - to reduce fever and relieve pain.
- Ibuprofen as an alternative for fever reduction.
- Antihistamines - to reduce allergic reactions.
Disease monitoring
Monitoring of patients with rubella includes monitoring for symptom progression and possible complications. The prognosis for most patients is good, and most cases occur with minimal sequelae. However, in pregnant women, the disease can lead to serious complications and surgery if fetal malformations are detected. Possible complications include:
- Inflammation of the brain (encephalitis).
- Hearing loss or cardiac abnormalities in a newborn.
Age-related features of the disease
Rubella is most common in childhood, especially among children under six years of age, since they are the ones who are most often not vaccinated. In adolescents and adults, the disease may manifest itself with more pronounced symptoms and be more severe. Rubella is especially dangerous for pregnant women, since the infection can lead to serious congenital anomalies.
Questions and Answers
- What are the main symptoms of rubella? The main symptoms are rash, fever, enlarged lymph nodes, conjunctivitis and catarrhal phenomena.
- How is rubella transmitted? Rubella is transmitted by airborne droplets, through contact with infected people.
- How can the disease be prevented? The main method of prevention is vaccination against rubella, which is recommended in childhood.
- Who is at risk for rubella? Unvaccinated people, pregnant women, and people with weakened immune systems.
- What are the possible complications of rubella in pregnant women? Complications may include fetal defects such as deafness and heart abnormalities.
